Related Experiment Video
Updated: Jun 28, 2026

12:31
In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
[Connective tissue dysplasia, magnesium, and nucleotide polymorphisms]
Kardiologiia
|November 11, 2008
Summary
Undifferentiated connective tissue dysplasia (UCTD) is common and linked to other diseases. This study identifies nucleotide polymorphisms for UCTD diagnostics and magnesium therapy effectiveness.
Area of Science:
- Connective tissue disorders
- Genetics
- Pharmacogenomics
Context:
- Undifferentiated connective tissue dysplasia (UCTD) is a prevalent condition with significant health implications.
- UCTD is associated with various comorbidities affecting cardiology, neurology, rheumatology, and pulmonology.
- Personalized therapeutic strategies, including magnesium-based treatments, are crucial for managing UCTD.
Purpose:
- To identify nucleotide polymorphisms for enhanced UCTD diagnostics.
- To explore genetic markers for predicting magnesium treatment efficacy in UCTD patients.
- To integrate genetic data with clinical diagnostics for personalized UCTD management.
Summary:
- This research proposes specific nucleotide polymorphisms for genetic association studies in undifferentiated connective tissue dysplasia (UCTD).
- The identified polymorphisms are suggested for use in diagnosing UCTD and predicting the effectiveness of magnesium-based therapies.
- The selection process involved analyzing proposed molecular mechanisms, published data, and functional effects of nucleotide and amino acid substitutions.
Impact:
- Advances the field of post-genomic medical research by incorporating nucleotide polymorphism data into UCTD diagnostics.
- Facilitates the development of personalized medicine approaches for UCTD patients.
- Provides a foundation for future genetic association studies and pharmacogenomic investigations in connective tissue disorders.
Related Concept Videos
Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Cohesins
Cohesin protein complexes are a molecular glue that holds two sister chromatids together. They play an important role both in mitosis and meiosis. In mitosis, all cohesin complexes present on the chromosomes are removed before the start of the anaphase stage.
Cohesin complexes in Meiotic Division
Meiosis involves two distinct rounds of chromosomal segregation and cell divisions— Meiosis I followed by Meiosis II – producing four daughter cells. Meiosis I includes the separation of homologous...
Cohesin complexes in Meiotic Division
Meiosis involves two distinct rounds of chromosomal segregation and cell divisions— Meiosis I followed by Meiosis II – producing four daughter cells. Meiosis I includes the separation of homologous...
Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Cytoskeletal Linker Proteins - Plakins
Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
